Study Suggests Johnson & Johnson Vaccine Is Significantly Less Effective Against Delta Variant

Study Suggests Johnson & Johnson Vaccine Is Significantly Less Effective Against Delta Variant

After weeks of minimal reported coronavirus cases, the numbers are trending back up.

In fact, statewide cases are up over 80 percent in the last week.

And a new study suggests the Johnson & Johnson vaccine is significantly less effective against this variant; KDKA's Nicole Ford reports.